首页> 外文期刊>American Journal of Kidney Diseases: The official journal of the National Kidney Foundation >Renal Leukocyte Chemotactic Factor 2 (LECT2) Amyloidosis in First Nations People in Northern British Columbia, Canada: A Report of 4 Cases
【24h】

Renal Leukocyte Chemotactic Factor 2 (LECT2) Amyloidosis in First Nations People in Northern British Columbia, Canada: A Report of 4 Cases

机译:加拿大北不列颠哥伦比亚省原住民的肾白细胞趋化因子2(LECT2)淀粉样变性:4例报告

获取原文
获取原文并翻译 | 示例
           

摘要

Leukocyte chemotactic factor 2 (LECT2) amyloidosis is a recently identified type of amyloidosis that may represent an underdiagnosed cause of chronic kidney disease. LECT2 amyloidosis typically is reported as being renal limited and, in the United States, more prevalent in Hispanic patients. We add to the epidemiologic data of this condition by describing 4 First Nations people from Northern British Columbia, Canada, who presented with slowly progressive chronic kidney disease that was found to be due to LECT2 amyloidosis. (C) 2014 by the National Kidney Foundation, Inc.
机译:白细胞趋化因子2(LECT2)淀粉样变性是最近发现的一种淀粉样变性,可能代表了慢性肾脏疾病的未被充分诊断的原因。 LECT2淀粉样变性病通常被报告为肾脏受限,在美国,西班牙裔患者更为普遍。通过描述来自加拿大北不列颠哥伦比亚省的4个原住民,这些人的病情流行病学数据有所增加,这些人表现出缓慢进展的慢性肾脏疾病,该疾病是由LECT2淀粉样变性引起的。 (C)美国国家肾脏基金会,2014年。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号